Which drug is a depolarizing neuromuscular blocker commonly used for rapid sequence intubation?

Prepare for the NBRC RRT-NPS Exam. Study with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Which drug is a depolarizing neuromuscular blocker commonly used for rapid sequence intubation?

Explanation:
Succinylcholine is a depolarizing neuromuscular blocker used for rapid sequence intubation. It works by briefly activating nicotinic receptors at the neuromuscular junction, causing an initial fasciculation and then sustained depolarization that prevents further contractions, leading to rapid, short-lived paralysis. Its onset is very fast (about 30–60 seconds) and its duration is short (roughly 5–10 minutes), which is ideal for RSI because it allows quick airway control with minimal time in apnea. It is quickly broken down by plasma pseudocholinesterase, so recovery is rapid. In pediatric patients this quick onset and offset are particularly advantageous, though clinicians watch for issues like bradycardia, hyperkalemia in certain conditions, and malignant hyperthermia risk. The other agents listed are nondepolarizing blockers; they paralyze without an initial depolarization and have slower onset and longer duration, making them less suitable for RSI in most cases.

Succinylcholine is a depolarizing neuromuscular blocker used for rapid sequence intubation. It works by briefly activating nicotinic receptors at the neuromuscular junction, causing an initial fasciculation and then sustained depolarization that prevents further contractions, leading to rapid, short-lived paralysis. Its onset is very fast (about 30–60 seconds) and its duration is short (roughly 5–10 minutes), which is ideal for RSI because it allows quick airway control with minimal time in apnea. It is quickly broken down by plasma pseudocholinesterase, so recovery is rapid. In pediatric patients this quick onset and offset are particularly advantageous, though clinicians watch for issues like bradycardia, hyperkalemia in certain conditions, and malignant hyperthermia risk. The other agents listed are nondepolarizing blockers; they paralyze without an initial depolarization and have slower onset and longer duration, making them less suitable for RSI in most cases.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy